ELV — Elevance Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual income statement for Elevance Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Total Premiums Earned
Net Investment Income
Realized & Unrealized Gains / Losses
Total Revenue	121,867	138,639	156,595	171,340	176,810
Losses, Benefits, and Adjustments
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	114,845	129,846	148,144	162,595	167,721
Operating Profit	7,022	8,793	8,451	8,745	9,089
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	6,238	7,995	7,600	7,715	7,904
Provision for Income Taxes
Net Income After Taxes	4,572	6,149	5,888	5,991	5,971
Minority Interest
Net Income Before Extraordinary Items
Net Income	4,572	6,158	5,894	5,987	5,980
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,572	6,158	5,894	5,987	5,980
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	20	25	24.4	27.7	25.9
Dividends per Share